Alnylam Pharmaceuticals
ALNY
#446
Rank
โ‚น4.744 T
Marketcap
โ‚น35,914
Share price
0.50%
Change (1 day)
73.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚น4.744 Trillion

As of December 2025 Alnylam Pharmaceuticals has a market cap of โ‚น4.744 Trillion. This makes Alnylam Pharmaceuticals the world's 446th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น4.744 T80.2%
2024โ‚น2.633 T31.68%
2023โ‚น1.999 T-17.35%
2022โ‚น2.419 T60.27%
2021โ‚น1.509 T36.7%
2020โ‚น1.104 T19.85%
2019โ‚น921.38 B78.63%
2018โ‚น515.80 B-35.88%
2017โ‚น804.49 B268.48%
2016โ‚น218.33 B-58.99%
2015โ‚น532.33 B12.16%
2014โ‚น474.61 B87.44%
2013โ‚น253.21 B382.76%
2012โ‚น52.45 B184.73%
2011โ‚น18.42 B-1.54%
2010โ‚น18.70 B-45.3%
2009โ‚น34.20 B-30.52%
2008โ‚น49.22 B5.79%
2007โ‚น46.53 B32.51%
2006โ‚น35.11 B202.91%
2005โ‚น11.59 B85.84%
2004โ‚น6.23 B

End of Day market cap according to different sources

On Dec 24th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚น4.744 Trillion
by Nasdaq info icon info icon
โ‚น4.744 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Arrowhead Pharmaceuticals
ARWR
โ‚น868.81 B-81.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.445 T 56.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น209.63 B-95.58%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น92.49 B-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚น50.63 B-98.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น23.885 T 403.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น10.501 T 121.33%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚น3.263 T-31.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel